Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis
暂无分享,去创建一个
D. Centonze | G. Marfia | C. Pozzilli | M. Sormani | D. Landi | M. Inglese | C. Gasperini | A. Gallo | P. Ragonese | R. Totaro | M. C. Buscarinu | R. Capra | M. Mirabella | E. D’Amico | F. Patti | L. Moiola | M. Amato | F. Granella | V. Brescia Morra | M. Clerico | V. Nociti | G. De Luca | M. Margoni | E. Portaccio | A. Bertolotto | C. Nicoletti | M. Di Filippo | E. Cocco | L. Lorefice | R. Lanzillo | C. Chisari | F. Bovis | D. Ferraro | G. Lus | E. Signoriello | M. Capobianco | R. Fantozzi | G. Salemi | M. Cellerino | E. Ferraro | C. Cordioli | S. Rasia | S. Malucchi | S. Bucello | A. Bianchi | F. Caleri | R. Cerqua | G. Borriello | P. Annovazzi | F. Vitetta | G. Mataluni | G. Cola | Alfonso Grimaldi | E. Curti | F. Pinardi | A. d'Ambrosio | S. Di Lemme
[1] R. Gold,et al. Multiple Sclerosis Disease Activity and Disability Following Discontinuation of Natalizumab for Pregnancy , 2022, JAMA network open.
[2] F. Piehl,et al. Disease activity in pregnancy and postpartum in women with MS who suspended rituximab and natalizumab , 2020, Neurology: Neuroimmunology & Neuroinflammation.
[3] C. Enzinger,et al. Pregnancy Outcomes in Patients With Multiple Sclerosis Exposed to Natalizumab—A Retrospective Analysis From the Austrian Multiple Sclerosis Treatment Registry , 2020, Frontiers in Neurology.
[4] G. Marfia,et al. Exposure to natalizumab during pregnancy and lactation is safe – Yes , 2020, Multiple sclerosis.
[5] Joan K. Morris,et al. A systematic review and meta-analyses of pregnancy and fetal outcomes in women with multiple sclerosis: a contribution from the IMI2 ConcePTION project , 2020, Journal of Neurology.
[6] J. Pelletier,et al. Maintenance of natalizumab during the first trimester of pregnancy in active multiple sclerosis , 2020, Multiple sclerosis.
[7] L. Wilkins. Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks , 2020, Neurology.
[8] A. Kermode,et al. Pregnancy outcomes amongst multiple sclerosis females with third trimester natalizumab use. , 2020, Multiple sclerosis and related disorders.
[9] Sara C. LaHue,et al. Navigating monoclonal antibody use in breastfeeding women , 2019, Neurology.
[10] M. Sormani,et al. Extending the Interval of Natalizumab Dosing: Is Efficacy Preserved? , 2019, Neurotherapeutics.
[11] S. Goelz,et al. Evaluation of natalizumab pharmacokinetics and pharmacodynamics with standard and extended interval dosing. , 2019, Multiple sclerosis and related disorders.
[12] C. Weinberg,et al. Role of maternal age and pregnancy history in risk of miscarriage: prospective register based study , 2019, BMJ.
[13] M. Roberts,et al. UK consensus on pregnancy in multiple sclerosis: ‘Association of British Neurologists’ guidelines , 2019, Practical Neurology.
[14] Xi Zhu,et al. Natalizumab exposure during pregnancy in multiple sclerosis: a systematic review , 2019, Journal of the Neurological Sciences.
[15] R. Alroughani,et al. Relapse occurrence in women with multiple sclerosis during pregnancy in the new treatment era , 2018, Neurology.
[16] C. Pozzilli,et al. Pregnancy decision-making in women with multiple sclerosis treated with natalizumab II : Maternal risks , 2022 .
[17] Roberta Lanzillo,et al. Pregnancy decision-making in women with multiple sclerosis treated with natalizumab , 2018, Neurology.
[18] David H. Miller,et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria , 2017, The Lancet Neurology.
[19] X. Montalban,et al. Reversibility of the effects of natalizumab on peripheral immune cell dynamics in MS patients , 2017, Neurology.
[20] S. Vukusic,et al. Natalizumab for the prevention of post-partum relapses in women with multiple sclerosis , 2015, Multiple sclerosis.
[21] R. Gold,et al. Natalizumab use during the third trimester of pregnancy. , 2014, JAMA neurology.
[22] J. Lechner-Scott,et al. Predictors and dynamics of postpartum relapses in women with multiple sclerosis , 2014, Multiple sclerosis.
[23] R. Gold,et al. Multiple sclerosis and pregnancy: experience from a nationwide database in Germany , 2012, Therapeutic advances in neurological disorders.
[24] C. Pozzilli,et al. Breastfeeding is not related to postpartum relapses in multiple sclerosis , 2011, Neurology.
[25] P. Ragonese,et al. The relapse rate of multiple sclerosis changes during pregnancy: a cohort study , 2004, Acta neurologica Scandinavica.
[26] M. Hutchinson,et al. Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. , 1999, The New England journal of medicine.
[27] J. Kurtzke. Rating neurologic impairment in multiple sclerosis , 1983, Neurology.
[28] R. Gold,et al. Long-term exposure to natalizumab during pregnancy - a prospective case series from the German Multiple Sclerosis and Pregnancy Registry , 2017 .